Summary of Recent Development in Multiplex Immunohistochemistry
Atlas Antibodies has introduced AtlasPlex™, a novel multiplex immunohistochemistry (IHC) kit that allows for customizable 3- or 5-plex panels from a comprehensive catalog of over 17,000 IHC-validated antibodies targeting more than 12,000 human genes. This advancement addresses challenges associated with traditional multiplex IHC workflows, which often involve rigid marker panels and complex setup processes.
The main benefit of AtlasPlex lies in its simplified approach: it eliminates the need for secondary antibodies, reducing the number of steps involved and optimizing the workflow for researchers. Importantly, it allows the combination of antibodies from various host species without stringent limitations, which enhances flexibility in experimental design. The kit utilizes a unique method where the horseradish peroxidase (HRP) is quenched rather than stripped between rounds, preserving the integrity of the tissue samples.
This technology significantly accelerates the research process, enabling the analysis of up to five markers in a single day—each cycle taking about 1.5 hours. Furthermore, each antibody is linked to specific tissue data from the Human Protein Atlas, ensuring that researchers can make informed decisions about protein expression before configuring their panels.
The implications of the AtlasPlex kit are substantial for various fields, including cancer research, immunology, and biomarker discovery. By facilitating reliable and adaptable multiplex staining on formalin-fixed, paraffin-embedded (FFPE) tissues, this innovation not only enhances the accuracy and efficiency of research but also contributes to a deeper understanding of tissue architecture and disease mechanisms. This development is pertinent for clinicians and policymakers as it may influence future research trajectories and therapeutic targets in organ transplantation and related medical fields.
Source: www.news-medical.net
